| Literature DB >> 17164655 |
Sameeramis Tootian1, Frouzandeh Mahjoubi, Mitra Rahnama, Fabyola Hormozian, Farzaneh Mortezapour, Faegeh Razazian, Farnoosh Manoochehri, Mahsa Zamanian, Fatemeh Nasiri, Saeedeh Soleymani, Ladan Seyedmortaz.
Abstract
We present our study on 318 patients suspected with Fanconi anemia (FA) referred to The Iranian Blood Transfusion Organization during the period of 4 years. Mitomycin C (MMC) was used as a DNA cross-linker to study chromosomal breakage. In total 61 positive cases were diagnosed cytogenetically. The ratio of women being affected was slightly higher than men. Comparison of several hematologic and clinical parameters in FA (MMC positive) and non-FA (MMC negative) patients showed no clinically significant differences. This study also indicates that this sort of test is very useful and essential for accurate diagnosis of patients with FA with or without congenital anomalies.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17164655 DOI: 10.1097/MPH.0b013e31802d3e1d
Source DB: PubMed Journal: J Pediatr Hematol Oncol ISSN: 1077-4114 Impact factor: 1.289